"The Natural Control of AIDS:
From Science to Healthcare"

Dr. Raxit Jariwalla during his lecture

Dr. Jariwalla presented numerous studies by other scientists that confirm the benefits of vitamins against AIDS, some as old as 20 years but neglected by pharmaceutically- oriented medicine:

Early clinical observations of AIDS patients have shown that high dosages of vitamin C stabilized CD4 cell counts and reduced other infections (Dr. Cathcart, 1985).

In HIV infected adults, vitamin C and E reversed damage to cells as a result of AZT (Dr. de la Asuncion and colleagues, 1998).

In a clinical study of the highest standard, supplementation with vitamins C (1000 mg) and E (800 IU daily) reduced cellular damage of oxidative stress and decreased viral load in the blood (Dr. Allard and colleagues, 1998).

In a pilot study, short-term administration of high doses of N-acetyl cysteine (a natural substance) with vitamin C improved immune responses and lowered viral load in patients with the most advanced AIDS (Dr. Aukrust and colleagues, 2000).

In a clinical study, vitamin C intake (from multivitamin supplementation) was associated with reduced risk of AIDS development in HIV-positive men (Dr. Abrams and colleagues,1993 / Dr. Tang and colleagues 1993).

A study sponsored by the WHO in 481 HIV-infected men and women living in Thailand document significant health improvements after 48 weeks of using multiple vitamin doses (Dr. Jiamton and colleagues, Dr. Raxit Jariwalla AIDS, 2003).

The vicious cycle of malnutrition and immunodeficiency

Prof. Sam Mhlongo

Prof Samuel Mhlongo MEDUNSA

Prof. Sam Mhlongo holds several medical degrees from universities in the United Kingdom. He is chief specialist and chief family practitioner in the Department of Family Medicine and Primary Health Care, Medical University of Southern Africa (MEDUNSA).

Acquired Immune Deficiency Syndrome (AIDS) and its defining diseases (fever, diarrhea, persistent cough, weight loss and tuberculosis) have long been associated with poverty, malnutrition and poor sanitation.

Prof. Mhlongo showed that the alleviation of poverty, improved nutrition and a better life for the African people in general will alleviate the burden of diseases that existed even before the advent of AIDS.

Using tuberculosis (TB) as one of the many examples, Professor Mhlongo argued that as one of the AIDS defining diseases today, TB was responsible for 61,292 deaths amongst Africans; 921 amongst Whites; 7481 amongst Coloureds and 990 amongst Asians way back in 1968.

He attributed the spread and deadliness of the disease to a wide range of micronutrient deficiencies in the human body, a consequence of malnutrition and poverty, made worse by deplorable sanitary and living standards.

These unenviable living conditions are still prevalent in African societies; hence the usual susceptibility to bacterial and viral infection. As the body is unable to fight diseases, people are vulnerable to all forms of fungal attacks.

Prof. Mhlongo emphasized that the nutritional status of people can thus influence the progression of the disease.

Accordingly, Africa remains at risk because the social and environmental factors responsible for the exponential increase in AIDS are still to be addressed.

He listed them as: over-crowding; sub-standard housing and living conditions; poverty; high rates of unemployment; psychosocial stress; physically violent crimes; family destruction and dysfunction, and street children now tagged AIDS orphans. For him, marketing AIDS as a deadly illness treatable only by ARV drugs by the big 3 drug producing countries (USA, Britain and Germany) is nothing more than an elaborate gimmick to further rob the African people of their meagre resources.

In South Africa alone, immunodeficiency is strongly correlated with rural and urban squalor where according to former Water Affairs Minister Ronnie Kasrils, about 21 million black people do not have access to safe and clean water.

The decline in infectious diseases was not achieved by clinical medicine or doctors, but rather by the tackling of public health issues through determined efforts by governments.

Toxic AIDS drugs under fire

David Rasnick PhD

Dr. Dave Rasnick during his lecture

Dr. Dave Rasnick is a senior researcher at the Dr. Rath Health Foundation in South Africa. He has more than 20 years experience in the pharmaceutical industry developing drugs for diabetes, cancer and for other chronic diseases. He has a wealth of experience on the toxicity of pharmaceutical drugs, particularly AIDS drugs.

Despite a concerted marketing campaign in the media promoting antiretroviral drugs (ARVs) as an answer to the AIDS epidemic, there is no credible scientific clinical evidence that ARVs save lives. AZT, the first ARV drug, was developed in the 1960s as cancer chemotherapy to kill dividing cells.

Chemotherapy drugs are chemical poisons. They work by killing cells - sick and healthy ones alike!

AZT was not used as cancer- chemotherapy because it was too toxic to be given to patients over a long period.

However, this drug was promoted as an anti-AIDS drug to the people in Africa and other poor regions of the world. Up until today there is not a single credible study documenting that AZT prolongs the life of an HIV-positive person.

Patients don't know:
Poison warning for the AIDS drug AZT

Moreover, ARVs cause severe side effects that result in new diseases and even death.

The most important side-effects of ARVs are:

• Decreased production of red and white blood cells
• Suppression of the immune system
• Fever
• Loss of memory
• Diarrhea and weight loss
• Damage to the kidneys and other organs
• Birth defects